How GLP-1 drugs reshape fat and metabolism
Part of Hormones & metabolism clinical trials.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20–65 years old
- BMI of 27 or higher (overweight or obese) with metabolic syndrome (high blood pressure, high cholesterol, and/or high blood sugar in a pattern doctors recognize)
- Stable doses of blood-pressure or cholesterol medications for at least 3 months
- No personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis, or diabetes
- Kidney and liver function well enough to safely participate (eGFR ≥30, no severe liver disease)
- No recent heart attack, stroke, or heart procedure in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to manage weight: taking a GLP-1 medication (like tirzepatide or semaglutide) versus making lifestyle changes without medication. It will help researchers learn which approach works best for people with overweight or obesity.
This study looks at how newer diabetes medications (semaglutide or tirzepatide) affect your body shape, muscle, and fat. If you have type 2 diabetes and just started one of these drugs, researchers want to learn more about changes in your body using imaging scans.
This study tests whether a GLP-1 receptor agonist (a type of medicine that helps control blood sugar and appetite) can improve metabolic health in people with early type 1 diabetes. It may be an option if you have already taken teplizumab to delay the disease or were recently diagnosed with type 1 diabetes.
This study looks at how GLP-1 medications affect your food cravings and choices after seeing food ads. If you are taking tirzepatide, it could help researchers understand how these ads affect you.
This study looks at whether doing exercise and a GLP-1 medicine (liraglutide or similar) can improve how your body uses insulin and how blood flows to your muscles. It is aimed at adults with metabolic syndrome who do not already have diabetes.
This study tests whether a newer class of weight-loss medicines (GLP-1 and GIP/GLP-1 analogues) can help people with excess body weight eat healthier and improve their metabolism and behavior. It may be a good option if you are an adult with overweight or obesity and haven't used these medicines recently.
Hear when a new Obesity and Metabolic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.